drugset / Trial / NCT04676035
The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole
NaSingle-groupOpen-labelBasic science
Summary
The DDI study had been designed to investigate the effect of SHR3680 on the pharmacokinetics of Midazolam, S-Warfarin and Omeprazole
Timeline
- Start
- 2020-06-15
- Primary completion
- 2022-01-26
- Completion
- 2022-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | — | — |
| Subject | Omeprazole | Other / unclassified | — | — |
| Subject | Rezvilutamide | Small molecule | 240 mg | — |
| Subject | Warfarin | Small molecule | — | — |
| Background | Vitamin K | Unknown | — | — |